Erratum: Heregulin-β1 regulates the estrogen receptor-α gene expression and activity via the ErbB2/PI 3-K/Akt pathway Retracted article: (Oncogene (2003) 22 (2073-2087) (DOI:10.1038/sj.onc.1206311);Heregulin-β1 regulates the estrogen receptor-α gene expression and activity via the ErbB2/PI 3-K/Akt pathway

Oncogene

Volumn 22, Issue 14, 2003, Pages 2073-2087

  Stoica, Gerald E ^a   Franke, Thomas F ^d   Wellstein, Anton ^a   Morgan, Elisha ^b   Czubayko, Frank ^c   List, Heinz Joachim ^a   Reiter, Ronald ^a   Martin, Mary Beth ^a   Stoica, Adriana ^a,b,d  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d NONE

Author keywords

Akt; ErbB2; Estrogen receptor; HRG 1

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 HYDROXYTAMOXIFEN; ANTIESTROGEN; CYSTEINE; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; GENE PRODUCT; GENISTEIN; HEREGULIN BETA1; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; RIBOZYME; UNCLASSIFIED DRUG; WORTMANNIN; AKT1 PROTEIN, HUMAN; ESTROGEN RECEPTOR; ONCOPROTEIN;

ARTICLE; CELL GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MULTIGENE FAMILY; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; CELL CULTURE; METABOLISM; PHOSPHORYLATION; PROTO ONCOGENE; RETRACTED ARTICLE;

MINK CELL FOCUS-FORMING VIRUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION; GENES, ERBB-2; HUMANS; NEUREGULIN-1; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ESTROGEN; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0038636495     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208526     Document Type: Erratum

References (118)

1. Aguilar Z, Akita RW, Finn RS, Ramos BL, Pegram MD, Kabbinavar FF, Pietras RJ, Pisacane P, Sliwkowski MX and Slamon DJ. (1999). Oncogene, 18, 6050-6062.
2. Ahmed NN, Franke TF, Bellacosa A, Datta K, Gonzalez-Portal ME, Taguchi T, Testa JR and Tsichlis PN. (1993). Oncogene, 8, 1957-1963.
3. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P and Hemmings BA. (1996). EMBO J., 15, 6541-6551.
4. Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC and McGuire WL. (1992). Hum. Pathol., 23, 974-979.
5. Andjelkovic M, Alessi DR, Meier R, Fernandez A, Lamb NJ, Frech M, Cron P, Cohen P, Lucocq JM and Hemmings BA. (1997). J. Biol. Chem., Dec 12; 272, 31515-31524.
6. Angus WG, Campaigne Larsen M and Jefcoate CR. (2000). Mol. Cell Endocrinol., 170, 1-13.
7. Antoniotti S, Maggiora P, Dati C and De Bortoli M. (1992). Eur. J. Cancer, 28, 318-321.
8. Bates NP and Hurst HC. (1997). Oncogene, 15, 473-481.
9. Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V, Ferrandina G, Panici PB, Mancuso S, Neri G and Testa JR. (1995). Int. J. Cancer, 64, 280-285.
10. Benchaibi M, Mallet F, Thoraval P, Savatier P, Xiao JH, Verdier G, Samarut J and Nigon V. (1989). Virology, 169, 15-26.
11. Benz CC, Scott GK, Sarup JC, Johnson RM, Tripathy D, Coronado E, Shepard HM and Osborne CK. (1993). Breast Cancer Res. Treat., 24, 85-95.
12. Berns EM, Foekens JA, van Putten WL, van Staveren IL, Portengen H, de Koning WC and Klijn JG. (1992). J. Steroid Biochem. Mol. Biol., 43, 13-19.
13. Berry M, Metzger D and Chambon P. (1990). EMBO J., 9, 2811-2818.
14. Berthois Y, Pourreau-Schneider N, Gandilhon P, Mittre H, Tubiana N and Martin PM. (1986). J. Steroid Biochem., 25, 963-972.
15. Brockhoff G, Heiss P, Schlegel J, Hofstaedter F and Knuechel R. (2001). Cytometry, 44, 338-348.
16. Burgering BM and Coffer PJ. (1995). Nature, 376, 599-602.
17. Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S and Nakshatri H. (2001). J. Biol. Chem., 276, 9817-9824.
18. Carraway III KL and Cantley LC. (1994). Cell, 78, 5-8.
19. Carraway III KL, Soltoff SP, Diamonti AJ and Cantley LC. (1995). J. Biol. Chem., 270, 7111-7116.
20. Chen X, Yeung TK and Wang Z. (2000). Biochem. Biophys. Res. Commun., 277, 757-763.
21. Cheng JQ, Altomare DA, Klein MA, Lee WC, Kruh GD, Lissy NA and Testa JR. (1997). Oncogene, 14, 2793-2801.
22. Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN and Testa JR. (1992). Proc. Natl. Acad. Sci. USA, 89, 9267-9271.
23. Chung YL, Sheu ML, Yang SC, Lin CH and Yen SH. (2002). Int. J. Cancer, 97, 306-312.
24. Daly RJ. (1999). Growth Factors, 16, 255-263.
25. Dauvois S, White R and Parker MG. (1993). J. Cell Sci., 106 (Part 4), 1377-1388.
26. De Potter CR, Beghin C, Makar AP, Vandekerckhove D and Roels HJ. (1990). Int. J. Cancer, 45, 55-58.
27. Dougall WC, Qian X, Peterson NC, Miller MJ, Samanta A and Greene MI. (1994). Oncogene, 9, 2109-2123.
28. Downward J. (1995). Nature, 376, 553-554.
29. El-Tanani MK and Green CD. (1997a). Mol. Endocrinol., 11, 928-937.
30. El-Tanani MK and Green CD. (1997b). J. Steroid Biochem. Mol. Biol., 60, 269-276.
31. Falls DL, Rosen KM, Corfas G, Lane WS and Fischbach GD. (1993). Cell, 72, 801-815.
32. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR and Tsichlis PN. (1995). Cell, 81, 727-736.
33. Garcia-Morales P, Saceda M, Kenney N, Kim N, Salomon DS, Gottardis MM, Solomon HB, Sholler PF, Jordan VC and Martin MB. (1994). J. Biol. Chem., 269, 16896-16901.
34. Grunt TW, Saceda M, Martin MB, Lupu R, Dittrich E, Krupitza G, Harant H, Huber H and Dittrich C. (1995). Int. J. Cancer, 63, 560-567.
35. Gullick WJ. (1990). Prog. Growth Factor Res., 2, 1-13.
36. Gullick WJ. (1991). Hum. Exp. Toxicol., 10, 398-400.
37. Gusterson BA, Gelber RD, Goldhirsch A, Price KN, Save-Soderborgh J, Anbazhagan R, Styles J, Rudenstam CM, Golouh R and Reed R et al. (1992). J. Clin. Oncol., 10, 1049-1056.
38. Harris JR, Lippman ME, Veronesi U and Willett W. (1992). N. Engl. J. Med., 327, 473-480.
39. Hemmings BA. (1997). Science, 277, 534.
40. Hoda K, Sawada H, Kihara T, Urushitani M, Nakamizo T, Akaike A and Shimohama S. (2000). J. Neurosci. Res., 60, 321-327.
41. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD et al. (1992). Science, 256, 1205-1210.
42. Houston SJ, Plunkett TA, Barnes DM, Smith P, Rubens RD and Miles DW. (1999). Br. J. Cancer, 79, 1220-1226.
43. Hynes NE and Stern DF. (1994). Biochim. Biophys. Acta, 1198, 165-184.
44. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA and Korach KS. (1992). Proc. Natl. Acad. Sci. USA, 89, 4658-4662.
45. Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS and McLachlan JA. (1993). Mol. Endocrinol., 7, 992-998.
46. Improta-Brears T, Whorton AR, Codazzi F, York JD, Meyer T and McDonnell DP (1999). Proc. Natl. Acad. Sci. USA, 96, 4686-4691.
47. Juhl H, Downing SG and Wellstein A. (1997). J. Biol. Chem., 272, 29482-29486.
48. Kato S. (2001). Breast Cancer, 8, 3-9.
49. Keshamouni VG, Mattingly RR and Reddy KB. (2002) J. Biol. Chem., 277, 22558-22565.
50. Kim HH, Sierke SL and Koland JG (1994). J. Biol. Chem., 269, 24747-24755.
51. Kim HP, Lee JY, Jeong JK, Bae SW, Lee HK and Jo I. (1999). Biochem. Biophys. Res. Commun., 263, 257-262.
52. King CR, Borrello I, Bellot F, Comoglio P and Schlessinger J. (1988). EMBO J., 7, 1647-1651.
53. Klippel A, Reinhard C, Kavanaugh WM, Apell G, Escobedo MA and Williams LT. (1996). Mol. Cell. Biol., 16, 4117-4127.
54. Konishi H, Kuroda S, Tanaka M, Matsuzaki H, Ono Y, Kameyama K, Haga T and Kikkawa U. (1995). Biochem. Biophys. Res. Commun., 216, 526-534.
55. Kraus MH, Issing W, Miki T, Popescu NC and Aaronson SA. (1989). Proc. Natl. Acad. Sci. USA, 86, 9193-9197.
56. Kurokawa H, Lenferink AE, Simpson JF, Pisacane PL, Sliwkowski MX, Forbes JT and Arteaga CL. (2000). Cancer Res., 60, 5887-5894.
57. Lichtner RB, Parczyk K, Birchmeier W and Schneider MR. (1999). J. Steroid Biochem. Mol. Biol., 71, 181-189.
58. Liu W, Li J and Roth RA. (1999). Biochem. Biophys. Res. Commun., 261, 897-903.
59. Liu Y, el-Ashry D, Chen D, Ding IY and Kern FG. (1995). Breast Cancer Res. Treat., 34, 97-117.
60. Lupu R, Cardillo M, Cho C, Harris L, Hijazi M, Perez C, Rosenberg K, Yang D and Tang C. (1996). Breast Cancer Res. Treat., 38, 57-66.
61. Lupu R and Lippman ME. (1993). Breast Cancer Res. Treat., 27, 83-93.
62. Lupu R, Wellstein A, Sheridan J, Ennis BW, Zugmaier G, Katz D, Lippman ME and Dickson RB. (1992). Biochemistry, 31, 7330-7340.
63. Marquez DC and Pietras RJ. (2001). Oncogene, 20, 5420-5430.
64. Martin MB, Franke TF, Stoica GE, Chambon P, Katzenellenbogen BS, Stoica BA, McLemore MS, Olivo SE and Stoica A. (2000). Endocrinology, 141, 4503-4511.
65. Matsuda S, Kadowaki Y, Ichino M, Akiyama T, Toyoshima K and Yamamoto T. (1993). Proc. Natl. Acad. Sci. USA, 90, 10803-10807.
66. McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB and Kern FG. (1993). Cancer Res., 53, 2168-2177.
67. Menard S, Tagliabue E, Campiglio M and Balsari A. (2000). J. Natl. Cancer Inst., 92, 943-944.
68. Mermelstein PG, Becker JB and Surmeier DJ. (1996). J. Neurosci., 16, 595-604.
69. Metzger D, Berry M, Ali S and Chambon P. (1995). Mol. Endocrinol., 9, 579-591.
70. Mimnaugh EG, Fairchild CR, Fruehauf JP and Sinha BK. (1991). Biochem. Pharmacol., 42, 391-402.
71. Miwa W, Yasuda J, Murakami Y, Yashima K, Sugano K, Sekine T, Kono A, Egawa S, Yamaguchi K, Hayashizaki Y and Sekiya T. (1996). Biochem. Biophys. Res. Commun., 225, 968-974.
72. Nakatani K, Thompson DA, Barthel A, Sakaue H, Liu W, Weigel RJ and Roth RA. (1999). J. Biol. Chem., 274, 21528-21532.
73. Nicholson RI, McClelland RA, Finlay P, Eaton CL, Gullick WJ, Dixon AR, Robertson JF, Ellis IO and Blamey RW. (1993). Eur. J. Cancer, 29A, 1018-1023.
74. Normanno N, Kim N, Wen D, Smith K, Harris AL, Plowman G, Colletta G, Ciardiello F and Salomon DS. (1995). Breast Cancer Res. Treat., 35, 293-297.
75. Orti E, Bodwell JE and Munck A. (1992). Endocrinol. Rev., 13, 105-128.
76. Paik S, Hazan R, Fisher ER, Sass RE, Fisher B, Redmond C, Schlessinger J, Lippman ME and King CR. (1990). J. Clin. Oncol., 8, 103-112.
77. Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB and Yarden Y. (1992). Cell, 69, 205-216.
78. Pierce JH, Arnstein P, DiMarco E, Artrip J, Kraus MH, Lonardo F, Di Fiore PP and Aaronson SA. (1991). Oncogene, 6, 1189-1194.
79. Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwkowski MX and Slamon DJ. (1995). Oncogene, 10, 2435-2446.
80. Plowman GD, Culouscou JM, Whitney GS, Green JM, Carlton GW, Foy L, Neubauer MG and Shoyab M. (1993). Proc. Natl. Acad. Sci. USA, 90, 1746-1750.
81. Prigent SA and Gullick WJ. (1994). EMBO J., 13, 2831-2841.
82. Puricelli L, Proiettii CJ, Labriola L, Salatino M, Balana ME, Ghiso JA, Lupu R, Pignataro OP, Charreau EH, Bal de Kier Joffe E and Elizalde PV. (2002). Int. J. Cancer, 100, 642-653.
83. Quenel N, Wafflart J, Bonichon F, de Mascarel I, Trojani M, Durand M, Avril A and Coindre JM. (1995). Breast Cancer Res. Treat., 35, 283-291.
84. Rawlings DJ, Saffran DC, Tsukada S, Largaespada DA, Grimaldi JC, Cohen L, Mohr RN, Bazan JF, Howard M, Copeland NG, Jenkins NA and Witte ON. (1993). Science, 261, 358-361.
85. Razandi M, Pedram A, Greene GL and Levin ER. (1999). Mol. Endocrinol., 13, 307-319.
86. Read LD, Greene GL and Katzenellenbogen BS. (1989). Mol. Endocrinol., 3, 295-304.
87. Read LD, Keith Jr D, Slamon DJ and Katzenellenbogen BS. (1990). Cancer Res., 50, 3947-3951.
88. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD and Glass DJ. (1999). Science, 286, 1738-1741.
89. Russell KS and Hung MC. (1992). Cancer Res., 52, 6624-6629.
90. Saceda M, Grunt TW, Colomer R, Lippman ME, Lupu R and Martin MB. (1996). Endocrinology, 137, 4322-4330.
91. Saceda M, Lippman ME, Chambon P, Lindsey RL, Ponglikitmongol M, Puente M and Martin MB. (1988). Mol. Endocrinol., 2, 1157-1162.
92. Sepp-Lorenzino L, Eberhard L, Ma Z, Cho S, Serve H, Liu F, Rosen N and Lupu R. (1996). Oncogene, 12, 1679-1687.
93. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW and Liao JK. (2000). Nature, 407, 538-541.
94. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. (1987). Science, 235, 177-182.
95. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF. (1989). Science, 244, 707-712.
96. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione RA, Vandlen RL and Carraway III KL. (1994). J. Biol. Chem., 269, 14661-14665.
97. Soltoff SP, Carraway 3rd KL, Prigent SA, Gullick WJ and Cantley LC. (1994). Mol. Cell. Biol., 14, 3550-3558.
98. Stevis PE, Deecher DC, Suhadolnik L, Mallis LM and Frail DE. (1999) Endocrinology, 140, 5455-5458.
99. Stoica A, Saceda M, Doraiswamy VL, Coleman C and Martin MB. (2000a). J. Endocrinol., 165, 371-378.
100. Stoica A, Saceda M, Fakhro A, Joyner M and Martin MB. (2000b). J. Cell. Biochem., 76, 605-614.
101. Stoica A, Saceda M, Fakhro A, Solomon HB, Fenster BD and Martin MB. (1997). Endocrinology, 138, 1498-1505.
102. Stoica GE, Franke TF, Moroni M, Muller M, Wellstein A, Morgan E, Martin MB and Stoica A. (2003a). The effect of estradiol on ER-a gene expression and activity can be modulated by Akt, Oncogene (submitted).
103. Stoica GE, Franke TF, Wellstein A, Czubayko F., List HJ, Reiter R, Martin MB, Morgan E and Stoica A. (2003b). Estradiol rapidly activates Akt via the ErbB2 signaling pathway. Mol. Endocrinol. (in press).
104. Sweeney C, Fambrough D, Huard C, Diamonti AJ, Lander ES, Cantley LC and Carraway III KL. (2001). J. Biol. Chem., 276, 22685-22698.
105. Tan M, Grijalva R and Yu D. (1999). Cancer Res., 59, 1620-1625.
106. Tang CK, Perez C, Grunt T, Waibel C, Cho C and Lupu R. (1996). Cancer Res., 56, 3350-3358.
107. Tauchi K, Hori S, Itoh H, Osamura RY, Tokuda Y and Tajima T. (1989). Virchows Arch. A. Pathol. Anat. Histopathol., 416, 65-73.
108. Taverna D, Antoniotti S, Maggiora P, Dati C, De Bortoli M and Hynes NE. (1994). Int. J. Cancer, 56, 522-528.
109. Tsutsui S, Ohno S, Murakami S, Hachitanda Y and Oda S. (2002). J. Surg. Oncol., 79, 216-223.
110. Tzahar E and Yarden Y. (1998). Biochim. Biophys. Acta., 1377, M25-M37.
111. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J et al. (1984). Nature, 309, 418-425.
112. Watters JJ, Campbell JS, Cunningham MJ, Krebs EG and Dorsa DM. (1997). Endocrinology, 138, 4030-4033.
113. Weigel NL. (1996). Biochem. J., 319 (Part 3), 657-667.
114. Wosikowski K, Schuurhuis D, Kops GJ, Saceda M and Bates SE. (1997). Clin. Cancer Res., 3, 2405-2414.
115. Wright C, Cairns J, Cantwell BJ, Cattan AR, Hall AG, Harris AL and Horne CH. (1992). Br. J. Cancer, 65, 271-274.
116. Yamamoto T, Akiyama T, Yokota J, Mori S and Toyoshima K. (1986). Princess Takamatsu Symp., 17, 203-210.
117. Yoo JY, Lessor T and Hamburger AW. (1998). Breast Cancer Res. Treat., 51, 71-81.
118. Zhou BP, Hu MC, Miller SA, Yu Z, Xia W, Lin SY and Hung MC. (2000) J. Biol. Chem., 275, 8027-8031.